Downregulation of Cdc6 and pre-replication complexes in response to methionine stress in breast cancer cells

Cell Cycle

Volumn 11, Issue 23, 2012, Pages 4414-4423

  Booher, Keith ^a,b   Lin, Da Wei ^a   Borrego, Stacey L ^a   Kaiser, Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Zymoresearch   (United States)

Author keywords

Cdc6; Cell cycle; Homocysteine; Methionine stress; S adenosylmethionine

Indexed keywords

AMINO ACID; CELL CYCLE PROTEIN 6; CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; HOMOCYSTEINE; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; METHIONINE; MINICHROMOSOME MAINTENANCE PROTEIN 2; MINICHROMOSOME MAINTENANCE PROTEIN 3; MINICHROMOSOME MAINTENANCE PROTEIN 7; PROTEIN KINASE B; PROTEIN ORC3; PROTEIN P21; PROTEIN P27; S ADENOSYLMETHIONINE; S6 KINASE; TUBULIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; CELL STRESS; CONTROLLED STUDY; DOWN REGULATION; METHYLATION;

EID: 84870887512     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.22767     Document Type: Article

References (37)

1. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008; 13:472-82; PMID:18538731; http://dx.doi.org/10.1016/j.ccr. 2008.05.005.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013.
3. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008; 134:703-7; PMID:18775299; http://dx.doi.org/10.1016/j.cell.2008.08.021.
4. Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012; 21:297-308; PMID:22439925; http://dx.doi.org/10.1016/j.ccr.2012.02.014.
5. Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, et al. Methionine dependency and cancer treatment. Cancer Treat Rev 2003; 29:489-99; PMID:14585259; http://dx.doi.org/10.1016/S0305-7372(03)00118-X.
6. Halpern BC, Clark BR, Hardy DN, Halpern RM, Smith RA. The effect of replacement of methionine by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci USA 1974; 71:1133-6; PMID:4524624; http://dx.doi.org/10.1073/pnas.71.4.1133.
7. Mecham JO, Rowitch D, Wallace CD, Stern PH, Hoffman RM. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 1983; 117:429-34; PMID:6661235; http://dx.doi.org/10. 1016/0006-291X(83)91218-4.
8. Stern PH, Wallace CD, Hoffman RM. Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol 1984; 119:29-34; PMID:6707100; http://dx.doi.org/10.1002/jcp.1041190106.
9. Hoffman RM, Erbe RW. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci USA 1976; 73:1523-7; PMID:179090; http://dx.doi.org/10.1073/pnas.73.5. 1523.
10. Lu S, Epner DE. Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells. Nutr Cancer 2000; 38:123-30; PMID:11341037; http://dx.doi.org/10.1207/S15327914NC381-17.
11. Kokkinakis DM, Liu X, Chada S, Ahmed MM, Shareef MM, Singha UK, et al. Modulation of gene expression in human central nervous system tumors under methionine deprivation-induced stress. Cancer Res 2004; 64:7513-25; PMID:15492278; http://dx.doi.org/10.1158/0008-5472.CAN-04-0592.
12. Breillout F, Hadida F, Echinard-Garin P, Lascaux V, Poupon MF. Decreased rat rhabdomyosarcoma pulmonary metastases in response to a low methionine diet. Anticancer Res 1987; 7(4B):861-7; PMID:3674775.
13. Guo H, Lishko VK, Herrera H, Groce A, Kubota T, Hoffman RM. Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res 1993; 53:5676-9; PMID:8242623.
14. Tisdale MJ, Jack GW, Eridani S. Differential sensitivity of normal and leukaemic haemopoietic cells to methionine deprivation by L-methioninase. Leuk Res 1983; 7:269-77; PMID:6855269; http://dx.doi.org/10.1016/0145-2126(83)90017- 6.
15. Pirotte B, Goldman S, Massager N, David P, Wikler D, Vandesteene A, et al. Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 2004; 45:1293-8; PMID:15299051.
16. Attia RR, Gardner LA, Mahrous E, Taxman DJ, Legros L, Rowe S, et al. Selective targeting of leukemic cell growth in vivo and in vitro using a gene silencing approach to diminish S-adenosylmethionine synthesis. J Biol Chem 2008; 283:30788-95; PMID:18753136; http://dx.doi.org/10.1074/jbc.M804159200.
17. Jani TS, Gobejishvili L, Hote PT, Barve AS, Joshi-Barve S, Kharebava G, et al. Inhibition of methionine adenosyltransferase II induces FasL expression, Fas-DISC formation and caspase-8-dependent apoptotic death in T leukemic cells. Cell Res 2009; 19:358-69; PMID:19048023; http://dx.doi.org/10.1038/cr.2008.314.
18. Kaiser P, Su NY, Yen JL, Ouni I, Flick K. The yeast ubiquitin ligase SCFMet30: connecting environmental and intracellular conditions to cell division. Cell Div 2006; 1:16; PMID:16895602; http://dx.doi.org/10.1186/1747- 1028-1-16.
19. Su NY, Flick K, Kaiser P. The F-box protein Met30 is required for multiple steps in the budding yeast cell cycle. Mol Cell Biol 2005; 25:3875-85; PMID:15870262; http://dx.doi.org/10.1128/MCB.25.10.3875-3885.2005.
20. Thomas D, Surdin-Kerjan Y. Metabolism of sulfur amino acids in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 1997; 61:503-32; PMID:9409150.
21. Hoffman RM, Jacobsen SJ, Erbe RW. Reversion to methionine independence by malignant rat and SV40-transformed human fibroblasts. Biochem Biophys Res Commun 1978; 82:228-34; PMID:208554; http://dx.doi.org/10.1016/0006-291X(78) 90600-9.
22. Hoffman RM, Jacobsen SJ, Erbe RW. Reversion to methionine independence in simian virus 40-transformed human and malignant rat fibroblasts is associated with altered ploidy and altered properties of transformation. Proc Natl Acad Sci USA 1979; 76:1313-7; PMID:220612; http://dx.doi.org/10.1073/pnas.76.3.1313.
23. Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 2010; 40:310-22; PMID:20965424; http://dx.doi.org/10.1016/j.mol-cel.2010.09.026.
24. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12:21-35; PMID:21157483; http://dx.doi.org/10.1038/nrm3025.
25. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 1991; 67:293-302; PMID:1655277; http://dx.doi.org/10.1016/0092-8674(91)90181-W.
26. Fry DW, Harvey PJ, Keller PR, Elliott WL, Meade M, Trachet E, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther 2004; 3:1427-38; PMID:15542782.
27. Bell SP, Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem 2002; 71:333-74; PMID:12045100; http://dx.doi.org/10.1146/annurev.biochem.71. 110601.135425.
28. Petersen BO, Wagener C, Marinoni F, Kramer ER, Melixetian M, Lazzerini Denchi E, et al. Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes Dev 2000; 14:2330-43; PMID:10995389; http://dx.doi.org/10.1101/gad.832500.
29. Zhang W, Braun A, Bauman Z, Olteanu H, Madzelan P, Banerjee R. Expression profiling of homocysteine junction enzymes in the NCI60 panel of human cancer cell lines. Cancer Res 2005; 65:1554-60; PMID:15735045; http://dx.doi.org/10. 1158/0008-5472.CAN-04-1554.
30. Lunn CL, Chrivia JC, Baldassare JJ. Activation of Cdk2/Cyclin E complexes is dependent on the origin of replication licensing factor Cdc6 in mammalian cells. Cell Cycle 2010; 9:4533-41; PMID:21088490; http://dx.doi.org/10.4161/cc. 9.22.13789.
31. Sotillo E, Garriga J, Padgaonkar A, Kurimchak A, Cook JG, Graña X. Coordinated activation of the origin licensing factor CDC6 and CDK2 in resting human fibroblasts expressing SV40 small T antigen and cyclin E. J Biol Chem 2009; 284:14126-35; PMID:19321444; http://dx.doi.org/10.1074/jbc.M900687200.
32. Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P. Cdk2 knockout mice are viable. Curr Biol 2003; 13:1775-85; PMID:14561402; http://dx.doi.org/10. 1016/j.cub.2003.09.024.
33. Tvegård T, Soltani H, Skjølberg HC, Krohn M, Nilssen EA, Kearsey SE, et al. A novel checkpoint mechanism regulating the G1/S transition. Genes Dev 2007; 21:649-54; PMID:17369398; http://dx.doi.org/10.1101/gad.421807.
34. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82:1107-12; PMID:2359136; http://dx.doi.org/10.1093/jnci/82.13.1107.
35. Keck JM, Summers MK, Tedesco D, Ekholm-Reed S, Chuang LC, Jackson PK, et al. Cyclin E overexpression impairs progression through mitosis by inhibiting APC(Cdh1). J Cell Biol 2007; 178:371-85; PMID:17664332; http://dx.doi.org/10. 1083/jcb.200703202.
36. Méndez J, Stillman B. Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol Cell Biol 2000; 20:8602-12; PMID:11046155; http://dx.doi.org/10.1128/MCB.20.22.8602-8612. 2000.
37. Pumiglia KM, Decker SJ. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 1997; 94:448-52; PMID:9012803; http://dx.doi.org/10.1073/pnas.94.2.448.